Aprea Therapeutics, Inc. (APRE)

0.9381 +0.13 (+16.51%) USD  |  NASDAQ  |  Aug 25, 16:00
0.98 +0.04 (+4.47%) After-Hours: 19:19
More

Aprea Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 13, 2026 --
August 12, 2026 --
August 10, 2026 --
June 01, 2026 --
May 15, 2026 --
May 13, 2026 --
May 07, 2026 --
April 06, 2026 --
March 31, 2026 --
March 16, 2026 --
February 09, 2026 --
Date Value
December 22, 2025 --
November 12, 2025 --
August 12, 2025 --
May 14, 2025 --
November 08, 2024 --
November 07, 2024 --
August 12, 2024 --
May 15, 2024 --
May 14, 2024 --
March 26, 2024 --
March 18, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Zymeworks, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Onconetix, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade